Therapeutics

Developing Next Generation Therapeutics for Healthy Life

Pipeline
Immunology
Project(Partners)
Target
Indication
Region
Discovery
Preclinical
IND
PH1
PH2
PH3
BLA Filing
view more

Batoclimab HBM9161(Hanall)

FcRn

MG

NMOSD

TED

ITP

CIDP

PV

Greater
China

Greater
China

Greater
China

Greater
China

Greater
China

Greater
China

view more

Tanfanercept HBM9036(Hanall)

TNFα

Dry Eye Disease

Greater
China

HBM9378

TSLP

Severe Asthma

Global

HBM9022(AbbVie; Utrecht University; Erasmus MC)

SARS-COV-2

COVID-19

Global license to AbbVie

Oncology/Immnuo-Oncology
Project(Partners)
Target
Indication
Region
Discovery
Preclinical
IND
PH1
PH2
PH3
BLA Filing
view more

HBM4003

CTLA-4

Advanced Solid Tumors

Advanced Melanoma&Other Solid Tumors

Advanced NSCLC&Other Solid Tumors

Global

Global

Global

HBM1007

CD73

Solid Tumors

Global

HBM7020

BCMAxCD3

Multiple Myeloma

Ex-Greater China

HBM7008

B7H4x4-1BB

Solid Tumors

Global

HBM1022

CCR8

Solid Tumors

Global

view more

HBM1020

B7H7

Solid Tumors

Global

  • HBM

  • Partner

  • Registrational Clinical Trial

  • Monotherapy

  • + PD-(L )1

Target and other details not disclosed due to commercial sensitivity

Publications